Cargando…

培美曲塞维持治疗恶性胸膜间皮瘤患者的疗效和安全性分析

BACKGROUND AND OBJECTIVE: Malignant pleural mesothelioma (MPM) is a highly aggressive disease arising from pleural mesothelial cells. Advanced pleural mesothelioma has a poor prognosis, with a median survival of no more than 15 months. First line standard chemotherapy regimen recommended is Pemetrex...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796129/
https://www.ncbi.nlm.nih.gov/pubmed/35078279
http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.48